Fulgent Investment Development Limited entered into an agreement to acquire 40.5% stake in Fujian Fujun Gene Biotechnology Co., Ltd. from Xilong Scientific Co., Ltd. for approximately CNY 120 million.
May 07, 2021
Share
Fulgent Investment Development Limited entered into an agreement to acquire 40.5% stake in Fujian Fujun Gene Biotechnology Co., Ltd. from Xilong Scientific Co., Ltd. (SZSE:002584) for approximately CNY 120 million on May 7, 2021. The board of Xilong Scientific approved the transaction. As of March 31, 2021, Fujian Fujun Gene Biotechnology recorded total assets of CNY 67.5 million and net assets of CNY 9.2 million.
XILONG SCIENTIFIC CO.,LTD., formerly XILONG CHEMICAL CO.,LTD., is principally engaged in the research, development, production and sale of chemical reagents. The Company primarily provides general chemical reagents, including ammonia water, sodium hydroxide, sulfuric acid, nitric acid, carbinol and ethanol; chemical reagents for printed circuit boards (PCBs), as well as super clean high purity chemical reagents. Its chemical reagents are mainly used in electronic information, daily chemicals, medicine, food, as well as sensitization industries. The Company is also involved in chemical raw material, bulk pharmaceutical, food additive, and in-vitro diagnostic substance businesses.
Fulgent Investment Development Limited entered into an agreement to acquire 40.5% stake in Fujian Fujun Gene Biotechnology Co., Ltd. from Xilong Scientific Co., Ltd. for approximately CNY 120 million.